mounjaro 10 mg kwikpen

Tirzepatide 10 mg KwikPen is a once-weekly injectable medication used for the treatment of type 2 diabetes and, in certain indications, for chronic weight management. As a dual GIP and GLP-1 receptor agonist, it helps improve blood sugar control by increasing insulin secretion when glucose levels are high, reducing glucagon release, slowing gastric emptying, and suppressing appetite. The 10 mg dose is typically used as a higher maintenance dose after gradual dose escalation to achieve better glycemic control and enhanced weight reduction. It may also help improve cardiovascular risk factors such as body weight and blood pressure. Common side effects include nausea, vomiting, diarrhea, decreased appetite, and abdominal discomfort, and it should be used under medical supervision.